Lupus Erythematosus, Cutaneous
Showing 1 - 25 of 3,248
Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))
Not yet recruiting
- Lupus Erythematosus, Cutaneous, Subacute
- Chronic Cutaneous Lupus Erythematosus
- BIIB059 (litifilimab)
- (no location specified)
Sep 12, 2023
Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)
Not yet recruiting
- Cutaneous Lupus Erythematosus
- Anifrolumab
- Placebo
- (no location specified)
Aug 22, 2023
Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)
Not yet recruiting
- Lupus Erythematosus, Systemic
- Lupus Erythematosus, Cutaneous
- Placebo
- PF-06823859
- (no location specified)
May 18, 2023
Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial (DS-7011a, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus Erythematosus
- DS-7011a
- Placebo
- (no location specified)
Dec 12, 2022
Cutaneous Lupus Erythematosus (CLE) Trial (GS-5718, GS-5718 Placebo)
Not yet recruiting
- Cutaneous Lupus Erythematosus (CLE)
- GS-5718
- GS-5718 Placebo
- (no location specified)
Dec 6, 2022
Cutaneous Lupus Erythematosus Trial in Dallas (UVA1 radiation treatment)
Completed
- Cutaneous Lupus Erythematosus
- UVA1 radiation treatment
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 30, 2022
Cutaneous Lupus Erythematosus Trial in United States (GS-5718, Placebo)
Terminated
- Cutaneous Lupus Erythematosus
- GS-5718
- Placebo
-
Beverly Hills, California
- +4 more
Nov 17, 2022
Healthy Volunteers, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) Trial in Sumida-ku (Placebo, KK4277)
Not yet recruiting
- Healthy Volunteers
- +2 more
- Placebo
- KK4277
-
Sumida-ku, Tokyo, JapanMedical Co. LTA Sumida Hospital
Jun 6, 2022
Clinical Severity of Cutaneous Lupus Erythematosus
Recruiting
- Cutaneous Lupus Erythematosus (CLE)
-
Philadelphia, Pennsylvania
- +1 more
Jan 29, 2022
Duke Lupus Registry
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus
-
Durham, North CarolinaDuke University Medical Center
Dec 19, 2022
Cutaneous Lupus Registry
Recruiting
- Lupus Erythematosus
-
Dallas, TexasUniversity of Texas Southwestern Medical Center Dallas
Nov 2, 2022
Lupus Erythematosus, Cutaneous Trial in Bern (Er:YAG laser)
Withdrawn
- Lupus Erythematosus, Cutaneous
- Er:YAG laser
-
Bern, SwitzerlandDepartment of dermatology, University Hospital Inselspital, Bern
Sep 13, 2021
Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial in Worldwide (M5049, Placebo)
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus Erythematosus
- M5049
- Placebo
-
Pleven, Bulgaria
- +10 more
Jul 18, 2022
Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous Trial in Worldwide (Deucravacitinib, Placebo)
Recruiting
- Lupus Erythematosus, Discoid
- Lupus Erythematosus, Subacute Cutaneous
- Deucravacitinib
- Placebo
-
Los Angeles, California
- +42 more
Oct 21, 2022
Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in West Hollywood
Completed
- Lupus Erythematosus, Cutaneous
- +4 more
- milatuzumab
- Placebo
-
West Hollywood, CaliforniaCedars Sinai Medical Center-Wallace Rheumatic Study Center
Aug 12, 2021
Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus
-
Ann Arbor, MichiganUniversity of Michigan Health System: Department of Internal Med
May 2, 2022
Cutaneous Lupus, Systemic Lupus Erythematosus Trial in Cincinnati, Cleveland (Tofacitinib)
Completed
- Cutaneous Lupus
- Systemic Lupus Erythematosus
-
Cincinnati, Ohio
- +1 more
Dec 19, 2022
Lupus Erythematosus, Cutaneous Trial in Germany (GSK2646264 1%, Placebo)
Completed
- Lupus Erythematosus, Cutaneous
- GSK2646264 1%
- Placebo
-
Tuebingen, Baden-Wuerttemberg, Germany
- +4 more
Mar 11, 2021
Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus Rash Trial in Changsha (nicotinamide)
Unknown status
- Cutaneous Lupus Erythematosus
- Systemic Lupus Erythematosus Rash
-
Changsha, Hunan, ChinaThe Second Xiangya Hospital of Central South University
Jan 31, 2021
Cutaneous Lupus Erythematosus Trial in Worldwide (SAR443122, Placebo)
Recruiting
- Cutaneous Lupus Erythematosus
- SAR443122
- Placebo
-
Thousand Oaks, California
- +54 more
Aug 1, 2022
Autoimmune Diseases, Pregnancy Related, Systemic Lupus Erythematosus Trial in Durham
Recruiting
- Autoimmune Diseases
- +6 more
-
Durham, North CarolinaDuke University
Feb 8, 2022
Lupus Erythematosus, Photosensitivity Conditions Trial in Philadelphia (Phototesting)
Completed
- Lupus Erythematosus
- Photosensitivity Conditions
- Phototesting
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 12, 2021
Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)
Completed
- Discoid Lupus Erythematosus
- Nicotinamide Topical
-
Cairo, EgyptAL-Azhar University Hospital
Oct 22, 2022
Systemic Lupus Erythematosus Trial (GLPG3667, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- GLPG3667
- Placebo
- (no location specified)
May 4, 2023